Reversal of Multidrug Resistance by the P-Glycoprotein Modulator, LY335979, from the Bench to the Clinic

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|8|1|39-50

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.1, 2001-01, pp. : 39-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SARFuture Perspective for Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 22, 2016-06 ,pp. : 2484-2508

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug Resistance Through the Spectacle of P-Glycoprotein

By  

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 281-297

Bentham Science Publishers

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite